Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2011 2
2012 1
2014 1
2015 1
2020 2
2021 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
When a study doesn't show what you hoped for.
Weber EJ. Weber EJ. Emerg Med J. 2022 Jul;39(7):492-493. doi: 10.1136/emermed-2021-212089. Epub 2021 Nov 17. Emerg Med J. 2022. PMID: 34789485 No abstract available.
WTO must ban harmful fisheries subsidies.
Sumaila UR, Skerritt DJ, Schuhbauer A, Villasante S, Cisneros-Montemayor AM, Sinan H, Burnside D, Abdallah PR, Abe K, Addo KA, Adelsheim J, Adewumi IJ, Adeyemo OK, Adger N, Adotey J, Advani S, Afrin Z, Aheto D, Akintola SL, Akpalu W, Alam L, Alava JJ, Allison EH, Amon DJ, Anderies JM, Anderson CM, Andrews E, Angelini R, Anna Z, Antweiler W, Arizi EK, Armitage D, Arthur RI, Asare N, Asche F, Asiedu B, Asuquo F, Badmus L, Bailey M, Ban N, Barbier EB, Barley S, Barnes C, Barrett S, Basurto X, Belhabib D, Bennett E, Bennett NJ, Benzaken D, Blasiak R, Bohorquez JJ, Bordehore C, Bornarel V, Boyd DR, Breitburg D, Brooks C, Brotz L, Campbell D, Cannon S, Cao L, Cardenas Campo JC, Carpenter S, Carpenter G, Carson RT, Carvalho AR, Castrejón M, Caveen AJ, Chabi MN, Chan KMA, Chapin FS, Charles T, Cheung W, Christensen V, Chuku EO, Church T, Clark C, Clarke TM, Cojocaru AL, Copeland B, Crawford B, Crépin AS, Crowder LB, Cury P, Cutting AN, Daily GC, Da-Rocha JM, Das A, de la Puente S, de Zeeuw A, Deikumah SKS, Deith M, Dewitte B, Doubleday N, Duarte CM, Dulvy NK, Eddy T, Efford M, Ehrlich PR, Elsler LG, Fakoya KA, Falaye AE, Fanzo J, Fitzsimmons C, Flaaten O, Florko KRN, Aviles MF, Folke C, F… See abstract for full author list ➔ Sumaila UR, et al. Science. 2021 Oct 29;374(6567):544. doi: 10.1126/science.abm1680. Epub 2021 Oct 28. Science. 2021. PMID: 34709891 No abstract available.
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease.
Berger-Sieczkowski E, Endmayr V, Haider C, Ricken G, Jauk P, Macher S, Pirker W, Högl B, Heidbreder A, Schnider P, Bradley-Zechmeister E, Mariotto S, Koneczny I, Reinecke R, Kasprian G, Weber C, Bergmann M, Milenkovic I, Berger T, Gaig C, Sabater L, Graus F, Gelpi E, Höftberger R. Berger-Sieczkowski E, et al. Acta Neuropathol. 2023 Oct;146(4):631-645. doi: 10.1007/s00401-023-02625-6. Epub 2023 Aug 30. Acta Neuropathol. 2023. PMID: 37646790 Free PMC article.
Three cases with short disease duration (median 1.25 years) only showed a primary age-related neurofibrillary pathology. Inflammatory infiltrates of T and B cells were mild to moderate and did not significantly differ between anti-IgLON5 disease cases with or without tauop …
Three cases with short disease duration (median 1.25 years) only showed a primary age-related neurofibrillary pathology. Inflammatory infilt …
Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.
Schneditz G, Rentner J, Roier S, Pletz J, Herzog KA, Bücker R, Troeger H, Schild S, Weber H, Breinbauer R, Gorkiewicz G, Högenauer C, Zechner EL. Schneditz G, et al. Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13181-6. doi: 10.1073/pnas.1403274111. Epub 2014 Aug 25. Proc Natl Acad Sci U S A. 2014. PMID: 25157164 Free PMC article.
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Weber S, van der Leest P, Donker HC, Schlange T, Timens W, Tamminga M, Hasenleithner SO, Graf R, Moser T, Spiegl B, Yaspo ML, Terstappen LWMM, Sidorenkov G, Hiltermann TJN, Speicher MR, Schuuring E, Heitzer E, Groen HJM. Weber S, et al. JCO Precis Oncol. 2021 Nov;5:1540-1553. doi: 10.1200/PO.21.00182. JCO Precis Oncol. 2021. PMID: 34994642
We evaluated if on-treatment changes of circulating tumor DNA (ctDNA) from ICI start (t(0)) to after two cycles (t(1)) assessed with a commercial panel could identify patients with NSCLC who would benefit from ICI. ...
We evaluated if on-treatment changes of circulating tumor DNA (ctDNA) from ICI start (t(0)) to after two cycles (t(1)) assesse …
14 results